✨ Free AI Report
BrainStorm Cell Therapeutics Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview BrainStorm Cell Therapeutics Inc.
Research Preview

BrainStorm Cell Therapeutics Inc.: Business Overview, Financials & Competitive Analysis

BrainStorm develops autologous stem cell therapies for neurodegenerative diseases such as ALS, MS, and Alzheimer's Disease. The proprietary NurOwn platform uses mesenchymal stem cells to produce neurotrophic factor-se...

Analyst-debate audio for BrainStorm Cell Therapeutics Inc.

AskCyborg analysts argue the bull and bear cases for BrainStorm Cell Therapeutics Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
BrainStorm Cell Therapeutics Inc. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

Early-stage biotech with meaningful ALS therapeutic potential but severe financial constraints and execution...

Read the full analyst-debate transcript →
Industry Biotechnology - Cell & Gene Therapy, Neurodegenerative Diseases
2 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest BrainStorm Cell Therapeutics Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

BrainStorm Cell Therapeutics Inc. Overview

Pro stress-test →

BrainStorm develops autologous stem cell therapies for neurodegenerative diseases such as ALS, MS, and Alzheimer's Disease. The proprietary NurOwn platform uses mesenchymal stem cells to produce neurotrophic factor-secreting cells designed to modulate neuroinflammation and promote neuroprotection.

Strategic Profile

Pro stress-test →

The company received FDA clearance for a Phase 3b trial (ENDURANCE) designed to support a potential BLA submission, planning to enroll approximately 200 participants. In February 2026, BrainStorm raised $2 million in strategic private placements to advance its regulatory and clinical objectives.

Competitive Landscape

Pro stress-test →

BrainStorm competes in the autologous stem cell therapy space for neurodegenerative disorders. Key competitors include Brainstorm's peer cell therapy developers targeting ALS and MS. The company's differentiation lies in its clinical data, Orphan Drug designations, and two active disease programs (ALS and MS) plus emerging exosome platform.

Industry Context

BrainStorm Cell Therapeutics Inc. operates in Biotechnology - Cell & Gene Therapy, Neurodegenerative Diseases.

Key facts

Headquarters: New York, United States

What the analysts stress-tested

The top findings that survived the multi-agent debate for BrainStorm Cell Therapeutics Inc..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when BrainStorm Cell Therapeutics Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Autologous Stem Cell TherapiesCell therapy competitors in neurodegenerative space→ALS Therapeutics PipelineTraditional small molecule and biologic ALS treatments→

Compare BrainStorm Cell Therapeutics Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

BrainStorm Cell Therapeutics Inc. operates in Biotechnology - Cell & Gene Therapy, Neurodegenerative Diseases. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Cell & Gene Therapy, Neurodegenerative Diseases research →
NEW · MCP server

Ask your AI assistant about BrainStorm Cell Therapeutics Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare BrainStorm Cell Therapeutics Inc. and its top competitor on Cyborg Score”
“What did BrainStorm Cell Therapeutics Inc. do this quarter?”
“Is BrainStorm Cell Therapeutics Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does BrainStorm Cell Therapeutics Inc. do?+
BrainStorm develops autologous stem cell therapies for neurodegenerative diseases such as ALS, MS, and Alzheimer's Disease. The proprietary NurOwn platform uses mesenchymal stem cells to produce neurotrophic factor-se...
What is BrainStorm Cell Therapeutics Inc.'s Cyborg Score?+
BrainStorm Cell Therapeutics Inc. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are BrainStorm Cell Therapeutics Inc.'s main competitors?+
Named competitors include Autologous Stem Cell Therapies, ALS Therapeutics Pipeline. The full competitive landscape is in the AskCyborg report.
How can I get the full BrainStorm Cell Therapeutics Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the BrainStorm Cell Therapeutics Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track BrainStorm Cell Therapeutics Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9National Bank of Pakistan9RENK Group AG9Lumentum Holdings Inc.9First Abu Dhabi Bank9The Travelers Companies, Inc.9BAE Systems plc9Arista Networks9KLA Corporation9Hermès International S.A.8Enerjisa Enerji A.Ş.8Emirates Central Cooling Systems Corporation8WALLIX Group8StealthGas Inc.8SofWave Medical Ltd.8Himalaya Shipping Ltd.8Bannerman Energy Ltd8Sembcorp Salalah Power & Water Company8MilDef Group